SCNI

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)

Stock · NASDAQ · Health Care

$0.7499as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

SCNI Listed Among Tuesday's Pre-Market Movers. Scinai Immunotherapeutics shares were highlighted in pre-market reports as one of the stocks moving significantly on Tuesday. The company is currently trading well below its 52-week high, reflecting its high-beta nature. These moves are part of broader healthcare sector activity noted in recent market sessions.

Active signals

Support level
$0.249438
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

What SCNI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown24-1.8%42%
Volume Spike21-22.6%19%
Bollinger Band Breakout15-20.1%7%
Any 20-session window (baseline)-8.7%28%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SCNI

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic ep…

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Employees
45

Fundamentals

1-day range
$0.732$0.8995
Market cap
$1.30M
P/E (trailing)
0.16
P/E (forward)
—
EPS (trailing)
$-0.01
Dividend yield
—
Beta
2.24
Avg. volume
2.14M
52-week range
$0.75$15.65
Next earnings: April 17, 2023 · EPS estimate $-10.80

Scinai Immunotherapeutics Ltd. American Depositary Shares Competitors

Chosen by industry and closest market cap.

  • SCNI
    Scinai Immunotherapeutics Ltd. American Depositary Shares
    $0.752
    ▼ 16.63%
    Market cap $1.30MP/E 0.16
    $0.75$15.65
  • BTTC
    Black Titan Corporation Ordinary Shares
    $0.368
    ▼ 6.84%
    Market cap $1.02MP/E —
    $0.3415$10.05
  • SLXN
    Silexion Therapeutics Corp Ordinary Shares
    $0.153
    ▼ 19.05%
    Market cap $1.90MP/E —
    $0.2362$42.6
  • TVGNW
    Tevogen Inc. Warrant
    $0.0689
    ▼ 1.57%
    Market cap $320.8KP/E —
    $0.0253$0.08
  • SLXNW
    Silexion Therapeutics Corp Warrant
    $0.0054
    ▼ 10.00%
    Market cap $21.3KP/E —
    $0.0051$0.1508
  • BKHA
    Black Hawk Acquisition Corporation Class A Ordinary Shares
    $6.01
    ▼ 12.26%
    Market cap $—P/E 136.64
    $9.5$23
  • CLDI
    Calidi Biotherapeutics Inc. Common Stock
    $0.837
    ▼ 3.79%
    Market cap $4.38MP/E —
    $0.82$27.84

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.